awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34260686-0FD228A9-0075-488F-A459-7AB561013A5C
Q34260686-0FD228A9-0075-488F-A459-7AB561013A5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34260686-0FD228A9-0075-488F-A459-7AB561013A5C
Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer.
P2860
Q34260686-0FD228A9-0075-488F-A459-7AB561013A5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34260686-0FD228A9-0075-488F-A459-7AB561013A5C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
58ed4e4b14bb03f7cba71405f6fa478c12668155
P2860
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.